Opendata, web and dolomites

OCTAV SIGNED

A novel approach to non-invasive and personalized skin cancer diagnosis

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 OCTAV project word cloud

Explore the words cloud of the OCTAV project. It provides you a very rough idea of what is the project "OCTAV" about.

paradigm    confocal    sme    covered    storage    worldwide    cloud    line    optical    approval    earlier    biopsies    capture    correlatively    benign    risk    reducing    oct    situ    tomography    presurgical    routine    definitive    invasive    fewer    deploying    assist    services    disruptive    conjunction    melanoma    diagnostic    octav    skin    segment    telepathology    issue    surgery    cancer    ing    damae    successfully    prototype    changing    cellular    medical    burden    designed    resolution    feasibility    clinicians    patient    lesions    imaging    full    layers    diagnosis    releasing    scaleup    trl9    dermatologists    lc    regulatory    aided    market    public    recurrence    adoption    handling    dermoscopy    dermatological    healthcare    industrialization    accurate    clinical    detection    cancers    preventing    performant    2017    device    first    trl6    consisting    instrument    private    company    practices    unnecessarily    interpretation    scars    financial    consolidated    images    initially    solution    phase2    software    validation    image    guide    larger    french    atlas    data    computer    platform    coherence    margins   

Project "OCTAV" data sheet

The following table provides information about the project.

Coordinator
DAMAE MEDICAL 

Organization address
address: BATIMENT 503 - CAMPUS SCIENTIFIQUE D'ORSAY
city: ORSAY
postcode: 91400
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Total cost 3˙485˙857 €
 EC max contribution 2˙400˙000 € (69%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2019
 Duration (year-month-day) from 2019-09-01   to  2021-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    DAMAE MEDICAL FR (ORSAY) coordinator 2˙400˙000.00

Map

 Project objective

French SME-company DAMAE Medical is facing skin cancer worldwide issue by developing the OCTAV Project, a new approach to dermatological diagnostic based on a disruptive Line-field Confocal Optical Coherence Tomography (LC-OCT) technology, in a novel hand-held imaging device. OCTAV is designed to capture in situ images of the skin layers with a cellular resolution. It is used in conjunction with dermoscopy to provide more accurate diagnosis, leading to fewer biopsies of benign lesions and earlier detection of melanoma (clinical use 1) and non-melanoma skin cancers (clinical use 2). It may also guide the surgery to provide more accurate presurgical margins (clinical use 3), preventing unnecessarily large scars and reducing the risk of recurrence. Correlatively, DAMAE is developing a full software solution, based on a data storage cloud-platform, a computer-aided software designed to assist dermatologists with OCTAV image interpretation, as well as telepathology and patient services. OCTAV device will initially be used by clinicians as a routine easy-handling diagnostic device in public practices (market segment 1). Implementation of OCTAV software will enable its adoption by a much larger market, consisting of private practices dermatologists (market segment 2). The approach will contribute to the development of skin cancer risk patient awareness, while changing the current paradigm through a timely, performant, and non-invasive approach, and releasing the financial burden on the healthcare system. Project OCTAV has successfully completed in 2017 a feasibility phase covered by the SME Instrument Phase 1, resulting in a TRL6 prototype of the technology and a first consolidated atlas of skin cancer clinical images. The main objective of this Phase2 is to scaleup the OCTAV solution to TRL9 through industrialization activities and by achieving a definitive market assessment, the clinical validation and the regulatory approval, before deploying the approach worldwide.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "OCTAV" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "OCTAV" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Dyme (2019)

Dyme gives its users complete control over their financial situation. The Dyme application provides insight into users’ spending and subscriptions, and lets users cancel, negotiate, or switch any cont

Read More  

HUD (2018)

COMMERCIALIZING THE FIRST HEAD-UP-DISPLAY FOR OFF-HIGHWAY VEHICLES

Read More  

PAROST (2019)

Disruptive technology for the identification, quantification and prediction of the evolution of damages in civil engineering structures that increases safety while reducing maintenance costs.

Read More